Novartis Institute for Tropical Diseases and Global Alliance for TB Drug Development Announce Five-Year Collaboration Targeted to Accelerate TB Treatment R&D
The Global Alliance for TB Drug Development (TB Alliance) and the Novartis Institute for Tropical Diseases (NITD) announced today a